10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

May 18, 2020

|

NEW YORK – 10x Genomics has countersued Bio-Rad Laboratories in a US District Court patent infringement suit.

Last week, 10x responded to Bio-Rad's allegations that 10x's Next GEM microfluidic chips infringe US Patent No. 10,190,115, "Methods and compositions for nucleic acid analysis" which covers the partitioning of a sample into droplets, in some cases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

To read the full story....

Breaking News

Genetics Testing Firm Prenetics Receives $15M Investment From Apis Partners, Alibaba

T Cell Gene Expression In Multiple Sclerosis CSF Reflects Elevated Activation, Cytotoxicity

People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More

New Products Posted to GenomeWeb: Sanford Burnham Prebys, 10x Genomics, Bio-Rad, More

In Brief This Week: Illumina, Natera, Sherlock Biosciences, and More

Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies

The Scan

Plans Out

CovidNudge Numbers

Science Papers Propose Group to Discuss Genome-Editing Tools, Markers of Diabetes Drug Response, More

Not Counting These

What's Popular?

Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies

Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

JumpCode Genomics Emerges From Stealth Mode With CRISPR-Based Library Prep Kits

CRISPR-Chip Maker Cardea Bio Raises $7.5M in First Close of Series A2 Financing Round

Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

Sponsorships